Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of FB1006 in treating amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• FB1006

Snippet

Sponsor: Peking University Third Hospital | Conditions: Sporadic and Familial Amyotrophic Lateral Sclerosis | Phase 4 | Status: RECRUITING